» Articles » PMID: 3143516

Clearance of Levonorgestrel from the Circulation Following Removal of NORPLANT Subdermal Implants

Overview
Journal Contraception
Publisher Elsevier
Date 1988 Nov 1
PMID 3143516
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The disappearance of levonorgestrel from plasma after the removal of NORPLANT subdermal implants was studied in 12 women who had been treated from 5.5 to 78 months. The existence of one or two half-lives for the rate of disappearance was assessed. The influence of body weight, body fat and length of treatment upon levonorgestrel clearance was studied through stepwise regression analysis. It was found that the levonorgestrel decay rate after implant removal can be entirely accounted assuming one half-life of 42 +/- 16 h (mean +/- SD; range 13 to 62 h). Stepwise regression analysis showed that levonorgestrel half-life is positively correlated with body weight and not significantly correlated with the length of treatment or body fat. It is concluded that, after long-term administration of levonorgestrel via subdermal implants, the major part of the steroid is cleared from plasma within 96 h and that only trace amounts are detected in the following days.

Citing Articles

Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial.

Nwaohiri A, Tang J, Stanczyk F, Chinula L, Hurst S, Davis N Contraception. 2017; 97(4):354-356.

PMID: 29246819 PMC: 5840008. DOI: 10.1016/j.contraception.2017.12.007.


Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing.

Edelman A, Cherala G, Blue S, Erikson D, Jensen J Contraception. 2016; 94(1):52-7.

PMID: 27000996 PMC: 4944814. DOI: 10.1016/j.contraception.2016.03.006.


Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Coukell A, Balfour J Drugs. 1998; 55(6):861-87.

PMID: 9617600 DOI: 10.2165/00003495-199855060-00019.


Levonorgestrel. Clinical pharmacokinetics.

FOTHERBY K Clin Pharmacokinet. 1995; 28(3):203-15.

PMID: 7758251 DOI: 10.2165/00003088-199528030-00003.